Hualan Biological Bacterin Inc.
Hualan Biological Vaccine Inc. engages in the research and development, production, and sale of vaccines and genetic engineering biological products in China. The company offers influenza vaccine (split virion), recombinant hepatitis B vaccine (hansenula polymorpha), meningococcal polysaccharide vaccine, influenza vaccine (split virion) quadrivalent, and meningococcal polysaccharide vaccine. It a… Read more
Hualan Biological Bacterin Inc. (301207) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.021x
Based on the latest financial reports, Hualan Biological Bacterin Inc. (301207) has a cash flow conversion efficiency ratio of 0.021x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥116.47 Million) by net assets (CN¥5.67 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Hualan Biological Bacterin Inc. - Cash Flow Conversion Efficiency Trend (2017–2024)
This chart illustrates how Hualan Biological Bacterin Inc.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Hualan Biological Bacterin Inc. Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Hualan Biological Bacterin Inc. ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Shenzhen Easttop Supply Chain Management Co Ltd
SHE:002889
|
-0.095x |
|
Yamashin-Filter Corp
PINK:YMFCF
|
0.015x |
|
Tyro Payments Ltd
AU:TYR
|
0.646x |
|
Chongqing Yukaifa Co Ltd
SHE:000514
|
0.003x |
|
Qingdao Hi-Tech Moulds & Plastics Technology Co. Ltd.
SHE:301022
|
0.050x |
|
Shanghai Prosolar Resources Development Co Ltd
SHG:600193
|
-0.100x |
|
Neogen Chemicals Limited
NSE:NEOGEN
|
-0.308x |
|
Road Environment Technology Co. Ltd. A
SHG:688156
|
N/A |
Annual Cash Flow Conversion Efficiency for Hualan Biological Bacterin Inc. (2017–2024)
The table below shows the annual cash flow conversion efficiency of Hualan Biological Bacterin Inc. from 2017 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥6.01 Billion | CN¥468.04 Million | 0.078x | -45.10% |
| 2023-12-31 | CN¥6.26 Billion | CN¥888.02 Million | 0.142x | +169.98% |
| 2022-12-31 | CN¥5.50 Billion | CN¥288.66 Million | 0.053x | -74.10% |
| 2021-12-31 | CN¥2.81 Billion | CN¥569.33 Million | 0.203x | -36.08% |
| 2020-12-31 | CN¥2.19 Billion | CN¥693.71 Million | 0.317x | +45.56% |
| 2019-12-31 | CN¥1.26 Billion | CN¥275.04 Million | 0.218x | +104.61% |
| 2018-12-31 | CN¥886.93 Million | CN¥94.46 Million | 0.106x | +196.26% |
| 2017-12-31 | CN¥616.78 Million | CN¥22.17 Million | 0.036x | -- |